We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

230 hedge funds and large institutions have $3.26B invested in Sage Therapeutics in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 72 increasing their positions, 75 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more funds holding in top 10

Funds holding in top 10: 3 → 7 (+4)

121% more call options, than puts

Call options by funds: $59.6M | Put options by funds: $27M

56% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 25

45% more capital invested

Capital invested by funds: $2.25B → $3.26B (+$1.01B)

6% more funds holding

Funds holding: 216 → 230 (+14)

0.81% less ownership

Funds ownership: 104.05% → 103.25% (-0.81%)

4% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 75

Holders
230
Holders Change
+14
Holders Change %
+6.48%
% of All Funds
4.64%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.14%
New
39
Increased
72
Reduced
75
Closed
25
Calls
$59.6M
Puts
$27M
Net Calls
+$32.6M
Net Calls Change
+$24M

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$47.7M
2
MWNA
Marshall Wace North America
New York
+$21.4M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$17.3M
4
LGM
Logos Global Management
California
+$12.7M
5
ACP
Acuta Capital Partners
California
+$11.4M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$31.9M
2
CCM
Camber Capital Management
Massachusetts
-$21.8M
3
Capital International Investors
Capital International Investors
California
-$18.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$17.2M
5
Two Sigma Investments
Two Sigma Investments
New York
-$15.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
FWM
201
Focused Wealth Management
New York
$6K – – –
KTC
202
Kistler-Tiffany Companies
Pennsylvania
$6K – – –
SSB
203
Sandy Spring Bank
Maryland
$6K – – –
PFGIA
204
Patriot Financial Group Insurance Agency
Massachusetts
$5K – – –
RWA
205
Ropes Wealth Advisors
Massachusetts
$5K – – –
SBL
206
Sargent Bickham Lagudis
Colorado
$5K – – –
MAM
207
Meeder Asset Management
Ohio
$5K +$253 +5 +6%
LJHT
208
Laurie J. Hall Trustee
$5K +$4.05K +80 New
QCG
209
Quadrant Capital Group
Ohio
$4K +$2.08K +41 +164%
BWA
210
BDO Wealth Advisors
Florida
$3K – – –
GWS
211
Glassman Wealth Services
Virginia
$3K – – –
LC
212
Lindbrook Capital
California
$3K – – –
LWCFA
213
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$3K – – –
WLPWM
214
Walled Lake Planning & Wealth Management
Illinois
$3K – – –
SFS
215
Sowell Financial Services
Arkansas
$2K -$6.08K -120 -77%
HR
216
Howe & Rusling
New York
$2K – – –
TFO
217
Tarbox Family Office
California
$2K – – –
ABC
218
Associated Banc-Corp
Wisconsin
$1K -$760 -15 -45%
BWM
219
BerganKDV Wealth Management
Minnesota
$1K – – –
Carson Wealth (CWM LLC)
220
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
EARNEST Partners
221
EARNEST Partners
Georgia
$1K – – –
JCM
222
Jacobi Capital Management
Pennsylvania
$1K – – –
Northwestern Mutual Wealth Management
223
Northwestern Mutual Wealth Management
Wisconsin
$1K +$507 +10 New
PFWA
224
Paces Ferry Wealth Advisors
Georgia
$1K +$760 +15 New
TPCW
225
TD Private Client Wealth
New York
$917 +$405 +8 +114%
7 8
9
10 11

SAGE Hedge Fund Activity: Q3 2020 in Review

230 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2020, worth a combined $3.26B — up 45% from $2.25B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new SAGE positions and 25 closed out — a net gain of 14 holders — while 72 added to existing stakes and 75 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $47.7M. The largest seller was State Street, cutting an estimated $31.9M.

  • 230 institutional investors held Sage Therapeutics (SAGE) as of Q3 2020, up from 216 in Q2 2020.
  • Funds reported $3.26B of Sage Therapeutics stock for Q3 2020, up 45% quarter-over-quarter.
  • 39 funds opened new Sage Therapeutics positions in Q3 2020 and 25 closed out, a net change of +14 holders.
  • The largest Sage Therapeutics buyer in Q3 2020 was Adage Capital Partners, an estimated $47.7M added.
  • The largest Sage Therapeutics seller in Q3 2020 was State Street, an estimated $31.9M sold.

Based on aggregated 13F filings for Q3 2020.